Related Experiment Video
Updated: Jul 24, 2026

14:55
Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy
Published on: September 17, 2017
Backbone dynamics and solution structure refinement of the 15N-labeled human oncogenic protein p13MTCP1: comparison
L Guignard1, A Padilla, J Mispelter
1Centre de Biochimie Structurale, CNRS-UMR 9955, INSERM-U414, Université de Montpellier I, Faculté de Pharmacie, France.
Journal of Biomolecular NMR
|August 26, 2000
Summary
Researchers refined the 3D structure of the oncogenic protein p13MTCP1 using nitrogen-15 labeling. This enhanced understanding of T-cell leukemia oncogenes may reveal new therapeutic targets.
Area of Science:
- Molecular Biology
- Structural Biology
- Oncology
Background:
- TCL1 and MTCP1 are oncogenes overexpressed in T-cell prolymphocytic leukemias.
- Chromosomal rearrangements lead to TCL1 and MTCP1 overexpression.
- p13MTCP1 and p14TCL1 are homologous oncogenic proteins, likely forming a new family.
Purpose of the Study:
- To gain deeper insights into the solution structure of the oncoprotein p13MTCP1.
- To refine the existing three-dimensional model of p13MTCP1.
- To investigate the dynamics of the protein backbone and identify potential binding surfaces.
Main Methods:
- Uniformly labeling p13MTCP1 with nitrogen-15.
- Utilizing 15N-edited 3D NMR experiments and homonuclear 2D NOESY at 800 MHz.
- Measuring 15N spin relaxation times and heteronuclear 15N[1H]NOEs at multiple magnetic field strengths.
Main Results:
- A refined 3D solution structure of p13MTCP1 was obtained, benefiting from 520 additional NOEs and near-complete phi angular restraints.
- Insights into the dynamics of the protein backbone were gained through relaxation measurements.
- A putative binding surface for this class of oncogenes was discussed based on the new structural and dynamic data.
Conclusions:
- The refined structure and dynamic data provide a more detailed understanding of p13MTCP1.
- This study contributes to the characterization of a new family of oncogenic proteins.
- The identified putative binding surface may offer targets for future therapeutic interventions in T-cell leukemias.

